Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Petricci

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Frontiers in Oncology|February 11, 2020
ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1Ferdinando Maria Milazzo, Loredana Vesci, Anna Maria Anastasi, et al.
Chemmedchem|December 18, 2007
A multidisciplinary approach for the identification of novel HIV-1 non-nucleoside reverse transcriptase inhibitors: S-DABOCs and DAVPsMarco Radi, Chiara Falciani, Lorenzo Contemori, et al.
Oncogene|May 7, 2021
Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanomaSilvia Pietrobono, Eugenio Gaudio, Sinforosa Gagliardi, et al.
Pharmacological Research|July 20, 2023
Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growthLuisa Maresca, Enrica Crivaro, Francesca Migliorini, et al.
Journal of Medicinal Chemistry|December 13, 2005
Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activityFabrizio Manetti, José A Esté, Imma Clotet-Codina, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 4, 2024
A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic miceMaria Laura De Angelis, Federica Francescangeli, Eleonora Aricò, et al.
Cell Death & Disease|September 1, 2018
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumorsMarialaura Petroni, Francesca Sardina, Paola Infante, et al.
Molecular Cell|December 10, 2013
DNA double-strand break repair pathway choice is directed by distinct MRE11 nuclease activitiesAtsushi Shibata, Davide Moiani, Andrew S Arvai, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 10, 2025
PHGDH drives 5-FU chemoresistance in colorectal cancer through the Hedgehog signalingCaterina Mancini, Giulia Lori, Gianluca Mattei, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Frontiers in Oncology|February 11, 2020
ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1Ferdinando Maria Milazzo, Loredana Vesci, Anna Maria Anastasi, et al.
Chemmedchem|December 18, 2007
A multidisciplinary approach for the identification of novel HIV-1 non-nucleoside reverse transcriptase inhibitors: S-DABOCs and DAVPsMarco Radi, Chiara Falciani, Lorenzo Contemori, et al.
Oncogene|May 7, 2021
Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanomaSilvia Pietrobono, Eugenio Gaudio, Sinforosa Gagliardi, et al.
Pharmacological Research|July 20, 2023
Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growthLuisa Maresca, Enrica Crivaro, Francesca Migliorini, et al.
Journal of Medicinal Chemistry|December 13, 2005
Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activityFabrizio Manetti, José A Esté, Imma Clotet-Codina, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 4, 2024
A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic miceMaria Laura De Angelis, Federica Francescangeli, Eleonora Aricò, et al.
Cell Death & Disease|September 1, 2018
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumorsMarialaura Petroni, Francesca Sardina, Paola Infante, et al.
Molecular Cell|December 10, 2013
DNA double-strand break repair pathway choice is directed by distinct MRE11 nuclease activitiesAtsushi Shibata, Davide Moiani, Andrew S Arvai, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 10, 2025
PHGDH drives 5-FU chemoresistance in colorectal cancer through the Hedgehog signalingCaterina Mancini, Giulia Lori, Gianluca Mattei, et al.
Pageof 6